Jose, S;
Quinn, K;
Dunn, D;
Cox, A;
Sabin, C;
Fidler, S;
UK CHIC, and UK HDRD Steering Committees;
(2016)
Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.
HIV Medicine
, 17
(5)
pp. 368-372.
10.1111/hiv.12302.
Preview |
Text
Jose_et_al-2015-HIV_Medicine.pdf Download (69kB) | Preview |
Abstract
No randomized controlled trials have yet reported an individual patient benefit of initiating combination antiretroviral therapy (cART) at CD4 counts > 350 cells/μL. It is hypothesized that earlier initiation of cART in asymptomatic and otherwise healthy individuals may lead to poorer adherence and subsequently higher rates of resistance development.
Archive Staff Only
View Item |